JB Chemicals & Pharmaceuticals Limited - Asset Resilience Ratio

Latest as of September 2025: 19.35%

JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) has an Asset Resilience Ratio of 19.35% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read JB Chemicals & Pharmaceuticals Limited balance sheet liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

Rs9.12 Billion

≈ $98.62 Million USD Cash + Short-term Investments

Total Assets

Rs47.12 Billion

≈ $509.63 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2006–2025)

This chart shows how JB Chemicals & Pharmaceuticals Limited's Asset Resilience Ratio has changed over time. See what is JB Chemicals & Pharmaceuticals Limited's book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down JB Chemicals & Pharmaceuticals Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs1.04 Billion	2.21%
Short-term Investments	Rs8.08 Billion	17.14%
Total Liquid Assets	Rs9.12 Billion	19.35%

Asset Resilience Insights

Good Liquidity Position: JB Chemicals & Pharmaceuticals Limited maintains a healthy 19.35% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

JB Chemicals & Pharmaceuticals Limited Industry Peers by Asset Resilience Ratio

Compare JB Chemicals & Pharmaceuticals Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	3.73%
Yuhan Corp. KO:000100	Drug Manufacturers - Specialty & Generic	0.99%
Tasly Pharmaceutical Group Co Ltd SHG:600535	Drug Manufacturers - Specialty & Generic	9.09%
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	Drug Manufacturers - Specialty & Generic	0.02%
Zhejiang Jiuzhou Pharm Co Ltd SHG:603456	Drug Manufacturers - Specialty & Generic	0.01%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	Drug Manufacturers - Specialty & Generic	0.29%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%

Annual Asset Resilience Ratio for JB Chemicals & Pharmaceuticals Limited (2006–2025)

The table below shows the annual Asset Resilience Ratio data for JB Chemicals & Pharmaceuticals Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	8.68%	Rs3.71 Billion ≈ $40.12 Million	Rs42.74 Billion ≈ $462.19 Million	-1.21pp
2024-03-31	9.89%	Rs3.95 Billion ≈ $42.71 Million	Rs39.94 Billion ≈ $431.95 Million	+3.05pp
2023-03-31	6.83%	Rs2.43 Billion ≈ $26.26 Million	Rs35.54 Billion ≈ $384.34 Million	+6.76pp
2022-03-31	0.07%	Rs19.26 Million ≈ $208.31K	Rs26.07 Billion ≈ $281.98 Million	-29.79pp
2021-03-31	29.86%	Rs6.68 Billion ≈ $72.28 Million	Rs22.38 Billion ≈ $242.04 Million	+9.86pp
2020-03-31	20.01%	Rs3.63 Billion ≈ $39.24 Million	Rs18.14 Billion ≈ $196.13 Million	-0.98pp
2019-03-31	20.99%	Rs3.76 Billion ≈ $40.65 Million	Rs17.91 Billion ≈ $193.69 Million	-1.10pp
2018-03-31	22.09%	Rs3.90 Billion ≈ $42.16 Million	Rs17.65 Billion ≈ $190.87 Million	+8.65pp
2017-03-31	13.44%	Rs2.25 Billion ≈ $24.33 Million	Rs16.74 Billion ≈ $181.04 Million	+0.90pp
2016-03-31	12.54%	Rs1.95 Billion ≈ $21.12 Million	Rs15.57 Billion ≈ $168.43 Million	-24.84pp
2015-03-31	37.38%	Rs5.56 Billion ≈ $60.12 Million	Rs14.87 Billion ≈ $160.84 Million	+0.58pp
2014-03-31	36.81%	Rs4.97 Billion ≈ $53.78 Million	Rs13.51 Billion ≈ $146.11 Million	+6.20pp
2013-03-31	30.61%	Rs3.98 Billion ≈ $43.04 Million	Rs13.00 Billion ≈ $140.61 Million	+5.65pp
2012-03-31	24.96%	Rs2.99 Billion ≈ $32.33 Million	Rs11.98 Billion ≈ $129.54 Million	+18.14pp
2011-03-31	6.82%	Rs681.15 Million ≈ $7.37 Million	Rs9.99 Billion ≈ $108.08 Million	-0.32pp
2010-03-31	7.13%	Rs596.82 Million ≈ $6.45 Million	Rs8.37 Billion ≈ $90.51 Million	-0.64pp
2009-03-31	7.77%	Rs579.99 Million ≈ $6.27 Million	Rs7.46 Billion ≈ $80.71 Million	-0.34pp
2008-03-31	8.11%	Rs601.32 Million ≈ $6.50 Million	Rs7.41 Billion ≈ $80.17 Million	+2.87pp
2007-03-31	5.24%	Rs373.14 Million ≈ $4.04 Million	Rs7.12 Billion ≈ $77.03 Million	-0.01pp
2006-03-31	5.25%	Rs265.04 Million ≈ $2.87 Million	Rs5.05 Billion ≈ $54.64 Million	--

pp = percentage points

About JB Chemicals & Pharmaceuticals Limited

NSE:JBCHEPHARM India Drug Manufacturers - Specialty & Generic

Market Cap

$3.55 Billion

Rs328.02 Billion INR

Market Cap Rank

#4460 Global

#189 in India

Share Price

Rs2043.40

Change (1 day)

-0.86%

52-Week Range

Rs1504.40 - Rs2138.60

All Time High

Rs2138.60